M. Robbins

发表

Genome structure of cucumber leaf spot virus: sequence analysis suggests it belongs to a distinct species within the Tombusviridae.

H. Damude, J. Miller, M. Robbins, 1997, Virus research.

siRNA and innate immunity.

A. Judge, I. Maclachlan, M. Robbins, 2009, Oligonucleotides.

Functional and intracellular localization properties of U6 promoter-expressed siRNAs, shRNAs, and chimeric VA1 shRNAs in mammalian cells.

J. Rossi, Shuo Gu, P. Salvaterra, 2008, RNA.

Sensing the danger in RNA

J. Rossi, M. Robbins, 2005, Nature Medicine.

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

I. Maclachlan, C. Mire, M. Robbins, 2014, Science Translational Medicine.

Genetic mapping of turnip mosaic virus resistance in Lactuca sativa

R. Michelmore, J. Laliberté, M. Robbins, 1994, Theoretical and Applied Genetics.

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

A. Lee, I. Maclachlan, C. Mire, 2017, The Journal of clinical investigation.

Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).

M. Robbins, J. Chantler, E. Pocock, 2003, Endocrinology.

Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: lack of requirement for oxidative metabolism.

M. Vadas, J. David, M. Robbins, 1981, Journal of immunology.

Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors

P. Harrigan, M. Robbins, P. Cheung, 2018, The Journal of infectious diseases.

Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.

C. Jobin, D. Metzger, P. Pozzilli, 2005, Human immunology.

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA

A. Judge, I. Maclachlan, C. Mire, 2013, The Journal of infectious diseases.

Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1

A. Judge, K. Mcclintock, I. Maclachlan, 2011 .

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice.

A. Judge, K. Mcclintock, I. Maclachlan, 2009, The Journal of clinical investigation.

Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.

X. Wang, C. Jobin, D. Metzger, 2005, Human immunology.

Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients

D. Campana, B. Barlogie, C. Rooney, 2015, Journal of immunotherapy.

2'-O-methyl-modified RNAs act as TLR7 antagonists.

A. Judge, K. Mcclintock, Ed Yaworski, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Molecular aspects of plant virus transmission by olpidium and plasmodiophorid vectors.

M. Robbins, R. Reade, D. Rochon, 2004, Annual review of phytopathology.

Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro

Yong-mei Song, J. Rossi, M. Behlke, 2006, Nature Biotechnology.

Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation.

A. Judge, K. Mcclintock, L. Palmer, 2008, Human gene therapy.

Misinterpreting the therapeutic effects of siRNA caused by immune stimulation

A. Judge, K. Mcclintock, L. Palmer, 2008 .

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

C. Tremblay, B. Brenner, D. Rouleau, 2018, Retrovirology.

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

Joshua C. Johnson, A. Judge, Vandana Sood, 2010, The Lancet.

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA

I. Maclachlan, C. Mire, M. Robbins, 2016, Nature Microbiology.

Interferon, Cytokine Induction, and other Potential In Vivo Toxicities

A. Judge, I. Maclachlan, M. Robbins, 2010 .

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

B. Brenner, J. Routy, M. Robbins, 2018, Retrovirology.

Evidence that Binding of Cucumber Necrosis Virus to Vector Zoospores Involves Recognition of Oligosaccharides

M. Robbins, D. Rochon, Kishore Kakani, 2003, Journal of Virology.

A cucumber necrosis virus variant deficient in fungal transmissibility contains an altered coat protein shell domain.

M. Robbins, R. Reade, D. Rochon, 1997, Virology.

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis

P. Harrigan, B. Yip, J. Joy, 2019, Open forum infectious diseases.

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

P. Harrigan, B. Yip, J. Montaner, 2017, AIDS.

Molecular analysis of the cucumber leaf spot virus genome.

Y. Xiang, M. Robbins, R. Reade, 2003, Virus research.

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA

I. Maclachlan, C. Mire, M. Robbins, 2016, Nature Microbiology.

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice.

A. Judge, K. Mcclintock, I. Maclachlan, 2009, The Journal of clinical investigation.